SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-003118
Filing Date
2024-03-13
Accepted
2024-03-13 17:00:20
Documents
14
Period of Report
2024-03-12
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K bpth-20240312x8k.htm   iXBRL 8-K 36058
  Complete submission text file 0001558370-24-003118.txt   155861

Data Files

Seq Description Document Type Size
2 EX-101.SCH bpth-20240312.xsd EX-101.SCH 3153
3 EX-101.LAB bpth-20240312_lab.xml EX-101.LAB 15926
4 EX-101.PRE bpth-20240312_pre.xml EX-101.PRE 10126
15 EXTRACTED XBRL INSTANCE DOCUMENT bpth-20240312x8k_htm.xml XML 4867
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS INC (Filer) CIK: 0001133818 (see all company filings)

IRS No.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36333 | Film No.: 24746817
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)